Sarah Mohs brings over 30 years of experience in regulatory, cGMP compliance and quality systems across small molecules, synthetic peptides/oligonucleotides, biologics, and drug-device combination products. Since joining Syner-G in 2016, she has led teams and provided expert CMC regulatory strategy of numerous global clinical trial dossiers, marketing applications, and post-approval supplements. 

She specializes in late-stage CMC development, accelerated regulatory pathways, and health agency interactions with experience in solid oral, sterile inhalation / injectable, and intraocular/intravesical products. Sarah’s background includes roles at TARIS Biomedical, Stryker Biotech, Sepracor, and PPD Development. She earned her degree in Chemistry from the University of Wisconsin–Madison.